CHEMOCENTRYX INC's ticker is CCXI and the CUSIP is 16383L106. A total of 66 filers reported holding CHEMOCENTRYX INC in Q2 2014. The put-call ratio across all filers is 0.61 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $2,882,000 | +1169.6% | 55,782 | +508.5% | 0.00% | – |
| Q2 2022 | $227,000 | -86.4% | 9,167 | -71.9% | 0.00% | -100.0% |
| Q1 2021 | $1,669,000 | +64.1% | 32,577 | +98.3% | 0.00% | – |
| Q4 2020 | $1,017,000 | +24.2% | 16,427 | +9.9% | 0.00% | – |
| Q3 2020 | $819,000 | -20.8% | 14,942 | -86.6% | 0.00% | – |
| Q2 2019 | $1,034,000 | -71.5% | 111,227 | -57.4% | 0.00% | -100.0% |
| Q1 2019 | $3,631,000 | +25.8% | 261,396 | -1.2% | 0.00% | +100.0% |
| Q4 2018 | $2,886,000 | +69.9% | 264,496 | +96.8% | 0.00% | 0.0% |
| Q3 2018 | $1,699,000 | +83.5% | 134,387 | +91.1% | 0.00% | – |
| Q2 2018 | $926,000 | +30766.7% | 70,321 | +11428.0% | 0.00% | – |
| Q3 2014 | $3,000 | – | 610 | +1933.3% | 0.00% | – |
| Q2 2014 | $0 | -100.0% | 30 | -98.0% | 0.00% | – |
| Q3 2013 | $9,000 | -59.1% | 1,532 | 0.0% | 0.00% | – |
| Q2 2013 | $22,000 | – | 1,532 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tri Locum Partners LP | 276,400 | $4,726,000 | 1.88% |
| TANG CAPITAL MANAGEMENT LLC | 500,000 | $8,550,000 | 1.78% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 94,300 | $7,131,000 | 1.72% |
| Integral Health Asset Management, LLC | 300,000 | $5,130,000 | 1.48% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 139,200 | $2,380,000 | 1.35% |
| MANGROVE PARTNERS IM, LLC | 686,300 | $11,736,000 | 1.05% |
| Ikarian Capital, LLC | 600,000 | $10,261,000 | 0.72% |
| Ikarian Capital, LLC | 600,000 | $10,260,000 | 0.72% |
| Sofinnova Investments, Inc. | 517,708 | $8,853,000 | 0.52% |
| Birchview Capital, LP | 25,000 | $428,000 | 0.29% |